These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 10972845)
1. Schistosoma mansoni gene GP22 encodes the tegumental antigen sm25: (1) antibodies to a predicted B-cell epitope of Sm25 cross-react with other candidate vaccine worm antigens; (2) characterization of a recombinant product containing tandem-repeats of this peptide as a vaccine. Petzke MM; Suri PK; Bungiro R; Goldberg M; Taylor SF; Ranji S; Taylor H; McCray JW; Knopf PM Parasite Immunol; 2000 Aug; 22(8):381-95. PubMed ID: 10972845 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of a protective peptide-based vaccine against Schistosoma mansoni. Tarrab-Hazdai R; Schechtman D; Arnon R Infect Immun; 1998 Sep; 66(9):4526-30. PubMed ID: 9712813 [TBL] [Abstract][Full Text] [Related]
3. Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family. Torres D; Espino AM Infect Immun; 2006 Aug; 74(8):4932-8. PubMed ID: 16861685 [TBL] [Abstract][Full Text] [Related]
4. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice. Tallima H; Tadros MM; El Ridi R Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620 [TBL] [Abstract][Full Text] [Related]
5. Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection. Martins VP; Morais SB; Pinheiro CS; Assis NR; Figueiredo BC; Ricci ND; Alves-Silva J; Caliari MV; Oliveira SC PLoS Negl Trop Dis; 2014 Mar; 8(3):e2750. PubMed ID: 24651069 [TBL] [Abstract][Full Text] [Related]
6. Immunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigens. Sulbarán G; Noya O; Brito B; Ballén DE; Cesari IM PLoS Negl Trop Dis; 2013; 7(6):e2254. PubMed ID: 23818994 [TBL] [Abstract][Full Text] [Related]
8. Identification of a novel antigen of Schistosoma mansoni shared with Plasmodium falciparum and evaluation of different cross-reactive antibody subclasses induced by human schistosomiasis and malaria. Pierrot C; Wilson S; Lallet H; Lafitte S; Jones FM; Daher W; Capron M; Dunne DW; Khalife J Infect Immun; 2006 Jun; 74(6):3347-54. PubMed ID: 16714563 [TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis. Riveau G; Deplanque D; Remoué F; Schacht AM; Vodougnon H; Capron M; Thiry M; Martial J; Libersa C; Capron A PLoS Negl Trop Dis; 2012; 6(7):e1704. PubMed ID: 22802974 [TBL] [Abstract][Full Text] [Related]
10. Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite. Prasanphanich NS; Luyai AE; Song X; Heimburg-Molinaro J; Mandalasi M; Mickum M; Smith DF; Nyame AK; Cummings RD Glycobiology; 2014 Jul; 24(7):619-37. PubMed ID: 24727440 [TBL] [Abstract][Full Text] [Related]
12. Mapping the epitopes of Schistosoma japonicum esophageal gland proteins for incorporation into vaccine constructs. Li XH; Vance GM; Cartwright J; Cao JP; Wilson RA; Castro-Borges W PLoS One; 2020; 15(2):e0229542. PubMed ID: 32107503 [TBL] [Abstract][Full Text] [Related]
13. Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons. Rojo JU; Melkus MW; Kottapalli KR; Okiya OE; Sudduth J; Zhang W; Molehin AJ; Carter D; Siddiqui AA PLoS One; 2017; 12(2):e0171677. PubMed ID: 28192534 [TBL] [Abstract][Full Text] [Related]
14. Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis. Hernández-Goenaga J; López-Abán J; Protasio AV; Vicente Santiago B; Del Olmo E; Vanegas M; Fernández-Soto P; Patarroyo MA; Muro A Front Immunol; 2019; 10():2498. PubMed ID: 31736947 [TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a specific IgG monoclonal antibody toward the Lewis x antigen using splenocytes of Schistosoma mansoni-infected mice. Mandalasi M; Dorabawila N; Smith DF; Heimburg-Molinaro J; Cummings RD; Nyame AK Glycobiology; 2013 Jul; 23(7):877-92. PubMed ID: 23542315 [TBL] [Abstract][Full Text] [Related]
16. New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74. Pearson MS; Jariwala AR; Abbenante G; Plieskatt J; Wilson D; Bottazzi ME; Hotez PJ; Keegan B; Bethony JM; Loukas A Hum Vaccin Immunother; 2015; 11(5):1251-7. PubMed ID: 26018444 [TBL] [Abstract][Full Text] [Related]
17. Identification of paramyosin T cell epitopes associated with human resistance to Schistosoma mansoni reinfection. Fonseca CT; Cunha-Neto E; Goldberg AC; Kalil J; de Jesus AR; Carvalho EM; Correa-Oliveira R; Hammer J; Sidney J; Sette A; Oliveira SC Clin Exp Immunol; 2005 Dec; 142(3):539-47. PubMed ID: 16297167 [TBL] [Abstract][Full Text] [Related]
18. Polymorphism associated with the Schistosoma mansoni tetraspanin-2 gene. Cupit PM; Steinauer ML; Tonnessen BW; Eric Agola L; Kinuthia JM; Mwangi IN; Mutuku MW; Mkoji GM; Loker ES; Cunningham C Int J Parasitol; 2011 Oct; 41(12):1249-52. PubMed ID: 21889508 [TBL] [Abstract][Full Text] [Related]
19. Antigenic epitope targets of rhesus macaques self-curing from Vance GM; Khouri MI; Neto APDS; James S; Leite LCC; Farias LP; Wilson RA Front Immunol; 2023; 14():1269336. PubMed ID: 38464672 [TBL] [Abstract][Full Text] [Related]